Literature DB >> 23375226

Structural analysis of the active sites of dihydrofolate reductase from two species of Candida uncovers ligand-induced conformational changes shared among species.

Janet L Paulsen1, Kishore Viswanathan, Dennis L Wright, Amy C Anderson.   

Abstract

A novel strategy for targeting the pathogenic organisms Candida albicans and Candida glabrata focuses on the development of potent and selective antifolates effective against dihydrofolate reductase. Crystal structure analysis suggested that an essential loop at the active site (Thr 58-Phe 66) differs from the analogous residues in the human enzyme, potentially providing a mechanism for achieving selectivity. In order to probe the role of this loop, we employed chemical synthesis, crystal structure determination and molecular dynamics simulations. The results of these analyses show that the loop residues undergo ligand-induced conformational changes that are similar among the fungal and human species.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23375226      PMCID: PMC3579541          DOI: 10.1016/j.bmcl.2013.01.008

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  14 in total

1.  Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine.

Authors:  Ajay N Jain
Journal:  J Med Chem       Date:  2003-02-13       Impact factor: 7.446

Review 2.  Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

Review 3.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

4.  In vitro biological activity and structural analysis of 2,4-diamino-5-(2'-arylpropargyl)pyrimidine inhibitors of Candida albicans.

Authors:  Janet L Paulsen; Jieying Liu; David B Bolstad; Adrienne E Smith; Nigel D Priestley; Dennis L Wright; Amy C Anderson
Journal:  Bioorg Med Chem       Date:  2009-06-17       Impact factor: 3.641

5.  Structure-guided development of efficacious antifungal agents targeting Candida glabrata dihydrofolate reductase.

Authors:  Jieying Liu; David B Bolstad; Adrienne E Smith; Nigel D Priestley; Dennis L Wright; Amy C Anderson
Journal:  Chem Biol       Date:  2008-09-22

6.  Highly efficient ligands for dihydrofolate reductase from Cryptosporidium hominis and Toxoplasma gondii inspired by structural analysis.

Authors:  Phillip M Pelphrey; Veljko M Popov; Tammy M Joska; Jennifer M Beierlein; Erin S D Bolstad; Yale A Fillingham; Dennis L Wright; Amy C Anderson
Journal:  J Med Chem       Date:  2007-02-02       Impact factor: 7.446

Review 7.  Epidemiology of invasive candidiasis.

Authors:  Maiken C Arendrup
Journal:  Curr Opin Crit Care       Date:  2010-10       Impact factor: 3.687

8.  Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis.

Authors:  John E Bennett; Koichi Izumikawa; Kieren A Marr
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

9.  Analysis of three crystal structure determinations of a 5-methyl-6-N-methylanilino pyridopyrimidine antifolate complex with human dihydrofolate reductase.

Authors:  Vivian Cody; Joseph R Luft; Walter Pangborn; Aleem Gangjee
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2003-08-19

10.  Probing the active site of Candida glabrata dihydrofolate reductase with high resolution crystal structures and the synthesis of new inhibitors.

Authors:  Jieying Liu; David B Bolstad; Adrienne E Smith; Nigel D Priestley; Dennis L Wright; Amy C Anderson
Journal:  Chem Biol Drug Des       Date:  2009-01       Impact factor: 2.817

View more
  7 in total

1.  Elucidating features that drive the design of selective antifolates using crystal structures of human dihydrofolate reductase.

Authors:  Kristen M Lamb; Narendran G-Dayanandan; Dennis L Wright; Amy C Anderson
Journal:  Biochemistry       Date:  2013-10-03       Impact factor: 3.162

2.  Crystal structures of Klebsiella pneumoniae dihydrofolate reductase bound to propargyl-linked antifolates reveal features for potency and selectivity.

Authors:  Kristen M Lamb; Michael N Lombardo; Jeremy Alverson; Nigel D Priestley; Dennis L Wright; Amy C Anderson
Journal:  Antimicrob Agents Chemother       Date:  2014-10-06       Impact factor: 5.191

3.  Direct Substitution of Arylalkynyl Carbinols Provides Access to Diverse Terminal Acetylene Building Blocks.

Authors:  Narendran G-Dayanandan; Eric W Scocchera; Santosh Keshipeddy; Heather F Jones; Amy C Anderson; Dennis L Wright
Journal:  Org Lett       Date:  2016-12-13       Impact factor: 6.005

4.  Propargyl-linked antifolates are dual inhibitors of Candida albicans and Candida glabrata.

Authors:  Narendran G-Dayanandan; Janet L Paulsen; Kishore Viswanathan; Santosh Keshipeddy; Michael N Lombardo; Wangda Zhou; Kristen M Lamb; Adrienne E Sochia; Jeremy B Alverson; Nigel D Priestley; Dennis L Wright; Amy C Anderson
Journal:  J Med Chem       Date:  2014-03-06       Impact factor: 7.446

5.  Propargyl-Linked Antifolates Are Potent Inhibitors of Drug-Sensitive and Drug-Resistant Mycobacterium tuberculosis.

Authors:  Behnoush Hajian; Eric Scocchera; Santosh Keshipeddy; Narendran G-Dayanandan; Carolyn Shoen; Jolanta Krucinska; Stephanie Reeve; Michael Cynamon; Amy C Anderson; Dennis L Wright
Journal:  PLoS One       Date:  2016-08-31       Impact factor: 3.240

6.  Dihydrofolate Reductase Is a Valid Target for Antifungal Development in the Human Pathogen Candida albicans.

Authors:  Christian DeJarnette; Arturo Luna-Tapia; Leanna R Estredge; Glen E Palmer
Journal:  mSphere       Date:  2020-06-24       Impact factor: 4.389

7.  Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase Trimethoprim Resistance in Aeromonas veronii.

Authors:  Dan Wang; Hong Li; Xiang Ma; Yanqiong Tang; Hongqian Tang; Dongyi Huang; Min Lin; Zhu Liu
Journal:  Front Microbiol       Date:  2021-11-24       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.